Inflexion is to acquire Sunovion Pharmaceuticals Europe (SPE) from US-based Sunovion Pharmaceuticals, according to a statement from parent company Sumitomo Dainippon Pharma.
Latest co-mingled vehicle is around a third larger than previous two programmes in the series
Deal with MidEuropa sealed after auction for ophthalmology group went quiet earlier this month
Vendor Horizon collected offers for the agricultural information services provider last week
Multi-family office will doubling down on manager selectivity, opportunities in secondaries, and family offices' interest in increasing PE exposure